Physical Therapists in Texas City, TX Accepting Medicare
5 Physical Therapists found. Showing 1 - 5
 Mr. John Allen Suggs, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6501 Memorial Drive, Ste A, Texas City, TX 77591 Phone: 409-935-1393 Fax: 409-935-3844 |
 Dr. Casey Clarissa Schlottman, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6807 Emmett F Lowry Expy Ste 103, Texas City, TX 77591 Phone: 409-935-2840 |
Matthew Wesley Lee, DPT, PT, C-RDN1 Physical Therapist Medicare: Medicare Enrolled Practice Location: 7111 Medical Center Dr Ste 111, Texas City, TX 77591 Phone: 409-935-2840 |
Dr. Brianna Lovett, PT, DPT Physical Therapist - Orthopedic Medicare: Medicare Enrolled Practice Location: 6807 Emmett F Lowry Expy Ste 103, Texas City, TX 77591 Phone: 409-935-2840 |
German Eduardo Isea Fernandez, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 6807 Emmett F Lowry Expy Ste 103, Texas City, TX 77591 Phone: 862-247-7441 |
News Archive
Positive correlation between working memory and mind wandering
Odds are, you're not going to make it all the way through this article without thinking about something else. In fact, studies have found that our minds are wandering half the time, drifting off to thoughts unrelated to what we're doing - did I remember to turn off the light? What should I have for dinner? A new study investigating the mental processes underlying a wandering mind reports a role for working memory, a sort of a mental workspace that allows you to juggle multiple thoughts simultaneously.
New data from Phase 2a trial support further development of BMS-945429/ALD518 monoclonal antibody for RA
Bristol-Myers Squibb Company and Alder Biopharmaceuticals today announced that new data from a dose-ranging Phase 2a trial support further development of BMS-945429/ALD518, an investigational monoclonal antibody directed against interleukin-6 (IL-6), as a potential treatment for rheumatoid arthritis (RA). The Phase 2a data will be presented in a scientific session on June 18, 2010, at the Annual Congress of the European League against Rheumatism (EULAR).
Collaborative approach may speed discovery of new preventive treatments for Alzheimer's disease
The future success of Alzheimer's prevention research could depend on the ability of researchers from different clinical trials to build collaborative relationships that facilitate the sharing of information, resources and expertise that may speed the discovery of new preventive treatments, according to leading Alzheimer's researchers who published a Perspectives article, "CAP-advancing the evaluation of preclinical Alzheimer disease treatments," online today in Nature Reviews Neurology.
Supreme Court will not review San Francisco health plan
"The justices on Monday denied an appeal from the Golden Gate Restaurant Association of an appeals court ruling upholding the program's requirement that employers help pay the bill or give their workers health coverage," The Associated Press reports. The decision allows the program to maintain its emphasis on sharing the financial responsibility for health care — a cost borne by the public, employers and employees, said Tangerine Brigham, director of Healthy San Francisco.
LifeMap Sciences, BioTime to acquire XenneX
BioTime, Inc. and its wholly owned subsidiary LifeMap Sciences today announced that they have signed a definitive agreement to acquire XenneX, Inc. through a merger of XenneX into LifeMap Sciences. The acquisition is expected to close within thirty days.
› Verified 4 days ago
Chiropractors
Optometrists
Occupational Therapists
Podiatrists
Physical Therapists
Speech-Language Pathologists
Audiologists